TNXP

Tonix Pharmaceuticals (NASDAQ:TNXP)shares are down 5% in a week. However, on Monday, the shares had a series of ups and

Earlier on in the year, there had been some stocks which had delivered remarkable gains on the backs of the

On Tuesday, the Tonix Pharmaceuticals Holding Corp (NASDAQ:TNXP) stock emerged as one of the significant movers and ended the day

Premarket trading period action can often provide investors with an idea about the direction of the market and this morning.

Shares of Tonix Pharmaceuticals (NASDAQ:TNXP), a company based in New York City and focusing on repurposed drugs for central nervous

Tonix Pharmaceuticals Inc. (NASDAQ:TNXP) is down 5% in a week. The company has appointed Carolyn E. Taylor to its Board

Tonix Pharmaceuticals Holding Corp (NASDAQ:TNXP) has dropped 25% in a month. Recently Tonix announced its inclusion in the Russell 3000